March 8, 2012 -- The National Institute on Alcohol Abuse and Alcoholism has funded a five-year, $21 million Integrative Neuroscience Initiative on Alcoholism grant to support a multi-site consortium led by an Oregon Health & Science University researcher.
March 7, 2012 -- Family, friends and colleagues will celebrate the life of the late Allan Price, former OHSU Foundation president and OHSU senior vice president for advancement, at a public memorial at 3:30 p.m. on Friday, March 23, at the Portland Art Museum, 1219 S.W. Park Ave.
Price, who was 56, drowned Feb. 17 while vacationing with his wife in Mexico.
Price assumed his jobs at OHSU and the OHSU Foundation, OHSU's nonprofit fundraising affiliate, in 2008.
February 17, 2012—The vote of Sen. Betsy Johnson (D-Scappoose), a crucial swing vote when the Senate decided to allow the Oregon Health Authority to move ahead with creating coordinated care organizations (CCOs) and overhauling the Oregon Health Plan’s delivery system, changed at the last moment because memos from the Department of Justice and Oregon Health & Science University (OHSU) revealed serious constitutional concerns about the proposed medical liability language for Senate Bill 1580.
Working in collaboration with Oregon’s university medical schools, hospitals and clinical research centers, biopharmaceutical companies are conducting or have conducted since 1999 more than 2,300 clinical trials of new medicines in the state, a released today shows.
February 1, 2012 -- Dr. Kent Thornburg, who teaches in the Division of Cardiovascular Medicine at Oregon Health & Science University and is known worldwide for his research into the developmental origins of disease – has been named interim director of the Bob and Charlee Moore Institute for Nutrition and Wellness, a new research and education center.
January 19, 2012 -- Oregon Health & Science University has joined the University Partnership of BioPontis Alliance, becoming the ninth premier institution engaged in the partnership to improve how discoveries made in laboratories at academic research centers translate into public benefit.
January 18, 2012 -- As policymakers wrestle with transforming Oregon’s healthcare system to control costs and improve quality, competition stands in the way, according to Dr. Charles Kilo, chief medical officer at Oregon Health & Science University.
December 6, 2011 – Oregon Health & Science University intends to restructure approximately $210 million of its variable rate debt, and replace old auction rate debt with a more stable funding structure following Friday’s board meeting.
Chief Financial officer Lawrence Furnstahl had urged the board to take advantage of favorable conditions -- annual fees for credit will drop by two-thirds, from 1.80 percent to less than .60 percent for a three-year commitment, saving the university approximately $2 million a year.
December 5, 2011 -- Yale School of Medicine has chosen the Oregon Evidence-based Practice Center at Oregon Health & Science University as one of two research centers that will independently review all clinical studies of a controversial product used in spinal surgeries to promote bone growth.
The selection of the Oregon Evidence-based Practice Center comes after Yale had entered into an unusual agreement with Medtronic, the manufacturer of the bone growth product — called bone morphogenetic protein-2 — to independently review the product.
